 VANCOUVER, BC and HOUSTON, Feb. 11, 2021 PRNewswire - ESSA Pharma Inc. ESSA, or the Company NASDAQ: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today will present preclinical and clinical pharmacology... 